Compare DexCom, Inc. (DXCM) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Wynn Resorts, Limited — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Wynn Resorts, Limited trades at $75.33 (market cap $7.75B). The key difference: DexCom, Inc. is far larger — about 4.1× Wynn Resorts, Limited's market cap, and Wynn Resorts, Limited pays a 1.33% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Wynn Resorts, Limited for 76 Days on average.
| DXCM | WYNN | |
|---|---|---|
Market Cap | $31.86B | $7.75B |
Volume | 3,607,070 | 2,243,813 |
Sector | Health | Consumer Cyclical |
52-Week High | $92.34 | $133.09 |
52-Week Low | $54.84 | $74.97 |
Typical Hold Time | 62 Days | 76 Days |
Enterprise Value | $31.32B | $17.99B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
Wynn Resorts (WYNN) trades at $75.15, up 0.24% on the day, with a bearish technical signal driven by moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing margin pressure in the U.S. Revenue growth is supported by Macau strength, though high capital expenditure for new projects in the UAE and elevated debt levels present financial risks. Analyst consensus remains strongly bullish with a $132.36 price target, but recent institutional activity shows mixed positioning.
The outlook for WYNN hinges on Macau recovery and successful execution of expansion projects, offering potential upside from current levels. However, risks include rising capex, competitive pressures, and macroeconomic sensitivity. Investors should weigh strong analyst sentiment against fundamental challenges and debt load.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
